Skip to content
Screener

Thermo Fisher Scientific TMO Life Sciences Solutions — Purchases of property, plant and equipment

Other segment segments

Laboratory Products and Biopharma Services
$298M-10.8%
Analytical Instruments
$36M-18.2%
Specialty Diagnostics
$35M+6.1%

Similar metrics at other companies

Corteva logo
CTVASeed — Purchases of property, plant and equipment
$108M+9.1%
Cimpress PLC logo
CMPRPrintBrothers — Purchases of property, plant and equipment
$5.53M+260%
Cimpress PLC logo
CMPRVista — Purchases of property, plant and equipment
$15.31M+39.8%
Corteva logo
CTVACrop Protection — Purchases of property, plant and equipment
$49M-10.9%
Cimpress PLC logo
CMPRNational Pen — Purchases of property, plant and equipment
$659K+98.5%
Cimpress PLC logo
CMPRAll Other Businesses — Purchases of property, plant and equipment
$911K-39.4%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.65B+26.0%
Enterprise value$248.77B+22.9%
P/E30.7×+4.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Unallocated amountsLife Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesConsolidated
Segment assets$98,434$3,490$3,104$1,332$6,921$113,281
Purchases of property, plant and equipment28203635259376
Depreciation of property, plant and equipment702624186306

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment?
Thermo Fisher Scientific (TMO) reported life sciences solutions — purchases of property, plant and equipment of $20M in Q1 2026.
How has Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment decreased by 53.5% year-over-year, from $43M to $20M.
What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment?
Over 3 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment has grown at a -42.7% compound annual growth rate (CAGR), from $810M to $152M.
What does life sciences solutions — purchases of property, plant and equipment mean?
This metric measures the cash outflows for capital expenditures specifically directed toward the Life Sciences Solutions segment. It reflects investments in new manufacturing capacity, laboratory equipment, and facility upgrades necessary to maintain competitive production capabilities. Tracking these expenditures provides insight into the segment's growth strategy and its commitment to long-term operational capacity.

Ask your AI about Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude